miR-148a/152 overexpression is associated with marked inhibition of breast cancer cell proliferation and angiogenesis by targeting IGF-1R and IRS1 and consequently their downstream signaling pathway (Xu et al., 2013). The gene discussed is IGF1R; the disease is breast carcinoma.